Rizki-Safitri et al., 2022 - Google Patents
Live functional assays reveal longitudinal maturation of transepithelial transport in kidney organoidsRizki-Safitri et al., 2022
View HTML- Document ID
- 10892369112504905653
- Author
- Rizki-Safitri A
- Gupta N
- Hiratsuka K
- Kobayashi K
- Zhang C
- Ida K
- Satlin L
- Morizane R
- Publication year
- Publication venue
- Frontiers in Cell and Developmental Biology
External Links
Snippet
Kidney organoids derived from hPSCs have opened new opportunities to develop kidney models for preclinical studies and immunocompatible kidney tissues for regeneration. Organoids resemble native nephrons that consist of filtration units and tubules, yet little is …
- 210000002220 Organoids 0 title abstract description 133
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Garreta et al. | Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells | |
Akram et al. | Live imaging of alveologenesis in precision-cut lung slices reveals dynamic epithelial cell behaviour | |
Lawlor et al. | Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation | |
Vedula et al. | A microfluidic renal proximal tubule with active reabsorptive function | |
Wesley et al. | Single-cell atlas of human liver development reveals pathways directing hepatic cell fates | |
Homan et al. | Bioprinting of 3D convoluted renal proximal tubules on perfusable chips | |
Rizki-Safitri et al. | Live functional assays reveal longitudinal maturation of transepithelial transport in kidney organoids | |
Lukacs et al. | Isolation, cultivation and characterization of adult murine prostate stem cells | |
Ciampi et al. | Engineering the vasculature of decellularized rat kidney scaffolds using human induced pluripotent stem cell-derived endothelial cells | |
Rybtsov et al. | Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region | |
Azkanaz et al. | Retrograde movements determine effective stem cell numbers in the intestine | |
Aceves et al. | 3D proximal tubule-on-chip model derived from kidney organoids with improved drug uptake | |
Yu et al. | Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis | |
Drakhlis et al. | Generation of heart-forming organoids from human pluripotent stem cells | |
Lai et al. | Reconstitution of bone-like matrix in osteogenically differentiated mesenchymal stem cell–collagen constructs: A three-dimensional in vitro model to study hematopoietic stem cell niche | |
Jeffries et al. | 3D micro-organisation printing of mammalian cells to generate biological tissues | |
Yang et al. | Trophoblast organoids with physiological polarity model placental structure and function | |
Dallas et al. | Time lapse imaging techniques for comparison of mineralization dynamics in primary murine osteoblasts and the late osteoblast/early osteocyte-like cell line MLO-A5 | |
Olijnik et al. | Generating human bone marrow organoids for disease modeling and drug discovery | |
Di Cio et al. | Vascularised cardiac spheroids-on-a-chip for testing the toxicity of therapeutics | |
Cahalan et al. | The sense of place in the immune system | |
Wang et al. | Developing a self‐organized tubulogenesis model of human renal proximal tubular epithelial cells in vitro | |
Wilm et al. | Restricted differentiative capacity of Wt1-expressing peritoneal mesothelium in postnatal and adult mice | |
Krause et al. | Cultured hepatocytes adopt progenitor characteristics and display bipotent capacity to repopulate the liver | |
US8192949B2 (en) | Microaggregates including endothelial cells |